Pharmacovigilance & Patient Safety

Our Commitment

Safeguarding Every Patient, Every Time

Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other medicine-related problem. At Curegix Medtech, patient safety is a core value woven into every product we develop and distribute.

Our programme ensures continuous post-market surveillance, systematic adverse event collection, and timely reporting to regulatory authorities in full compliance with Indian and international standards.

Report an Adverse Event

Our Pharmacovigilance Commitments

✓Continuous post-market safety monitoring of all products
✓Systematic collection and assessment of adverse drug reactions
✓Timely reporting to CDSCO and international regulatory bodies
✓Risk-benefit analysis for all formulations in our portfolio
✓Patient safety communication and healthcare professional alerts
✓Signal detection and periodic safety update reports (PSURs)
✓Training and awareness for distribution partners and healthcare staff

Our Process

How We Monitor Patient Safety

Detection

Collection of adverse event reports from patients, healthcare professionals, and scientific literature.

Assessment

Causality assessment and severity classification by qualified pharmacovigilance personnel following ICH guidelines.

Reporting

Timely submission to CDSCO and other relevant regulatory authorities as required by law.

Prevention

Risk minimisation measures, label updates, and proactive healthcare professional communication.

Patient Safety FAQs

Common Questions About Patient Safety

What should I do if I experience a side effect from a Curegix Medtech product?+

Please contact your healthcare professional immediately for medical guidance. You can also report the adverse event directly to us via our contact form or call +91 99708 53303. All reports are taken seriously and investigated thoroughly.

How do I report an adverse drug reaction?+

Adverse drug reactions can be reported through our website contact form, by email to info@curegixmedtech.com, or by calling +91 99708 53303. You can also report directly to CDSCO through the PvPI system.

What information is needed to report an adverse event?+

Please provide: the product name and batch number, description of the adverse event, date of occurrence, patient details (age, gender), and the reporter's contact information.

Are adverse event reports kept confidential?+

Yes. All patient information is handled with strict confidentiality in accordance with applicable privacy laws and pharmaceutical regulations.

What is CDSCO and why does it matter for patient safety?+

CDSCO (Central Drugs Standard Control Organisation) is India's national regulatory body for pharmaceuticals. Compliance with CDSCO guidelines ensures all products meet India's highest safety, quality, and efficacy standards.

Quality Assured ◆ GMP Certified ◆ Pan-India Distribution ◆ Pharmacovigilance ◆ Third-Party Manufacturing ◆ Aurangabad Maharashtra ◆ Quality Assured ◆ GMP Certified ◆ Pan-India Distribution ◆ Pharmacovigilance ◆ Third-Party Manufacturing ◆ Aurangabad Maharashtra ◆